Miura Global Management’s Pulmonx LUNG Stock Holding History

Miura Global Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-595,000	Closed	-$14.8M	–	24
2022 Q1	$14.8M	Sell	595,000 -550,000	-48%	-$14.2M	4.8%	7
2021 Q4	$36.7M	Buy	1,145,000 +85,000	+8%	+$3.1M	6.22%	5
2021 Q3	$38.1M	Buy	1,060,000 +490,000	+86%	+$19.3M	5.91%	4
2021 Q2	$25.1M	Buy	570,000 +165,000	+41%	+$7.18M	4.59%	6
2021 Q1	$18.5M	Buy	+405,000	New	+$23.2M	3.31%	15

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Miura Global Management's LUNG Position: Q2 2022 in Review

Miura Global Management sold out of Pulmonx (LUNG) in Q2 2022, closing a stake of 595,000 shares — an estimated $14.8M sold.

Miura Global Management first reported a position in LUNG in Q1 2021 and held it in 5 quarters. The position peaked at $38.1M in Q3 2021. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2022.

Miura Global Management reported no remaining Pulmonx position as of Q2 2022 after selling out during the quarter.
Miura Global Management sold 595,000 Pulmonx shares in Q2 2022, an estimated $14.8M.
Miura Global Management first reported a position in Pulmonx in Q1 2021 and held it in 5 quarters.
Miura Global Management's Pulmonx position peaked at $38.1M in Q3 2021.
107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2022.

Based on Miura Global Management's 13F filing for Q2 2022, filed 15 Aug 2022.